Sie suchten nach: carboxamide (Maltesisch - Englisch)

kategorija farmakoterapewtika: anti- epilletiċi, derivattivi tal- carboxamide kodiċi atc:
7 pharmacotherapeutic group: anti-epileptics, carboxamide derivatives; atc-code:

kategorija farmakoterapewtika: antiepilettiċi, derivattivi tal-carboxamide, kodiċi atc: n03af03.
pharmacotherapeutic group: antiepileptics, carboxamide derivatives; atc code: n03af03.

5-aminoimidazole-4-carboxamide (aic) jew metaboliti polari li ma ġewx identifikati.
5-aminoimidazole-4-carboxamide (aic) or unidentified polar metabolites.

kemm ribavirin u l-metaboliti tiegħu triazole carboxamide u triazole carboxylic acid jiġu eliminati permezz tal-kliewi.
both ribavirin and its triazole carboxamide and triazole carboxylic acid metabolites are also excreted renally.

3-methyl-(triazen-1-yl)imidazole-4-carboxamide (mtic).
3- methyl(triazen-1-yl)imidazole-4-carboxamide (mtic).

kategorija farmakoterapewtika: mediċini antiepilettiċi, derivattivi ta’ carboxamide, kodiċi atc: n03af04 mekkaniżmu ta’ azzjoni
pharmacotherapeutic group: antiepileptics, carboxamide derivatives, atc code: n03af04 mechanism of action

sensittività eċċesiva għas-sustanza attiva jew derivattivi carboxamide oħrajn (eż., carbamazepine, oxcarbazepine) jew għal xi sustanzi mhux attivi.
hypersensitivity to the active substance, to other carboxamide derivatives (e.g. carbamazepine, oxcarbazepine) or to any of the excipients.

temozolomide huwa triazene, li fil-ph fiżjoloġiku jinbidel malajr għas-sustanza attiva ta’ monomethyl triazenoimidazole carboxamide (mtic).
temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic ph to the active monomethyl triazenoimidazole carboxamide (mtic).

fi studju separat ta ’ fażi i, l- għotja ta ’ tmz ma ’ ranitidine ma bidilx il- grad ta ’ assorbiment ta ’ temozolomide jew l- esponiment għal metabolu attiv tiegħu monomethyl triazenoimidazole carboxamide (mtic).
5 in a separate phase i study, administration of tmz with ranitidine did not result in alterations in the extent of absorption of temozolomide or the exposure to its active metabolite monomethyl triazenoimidazole carboxamide (mtic).